IL1RAP and acute myeloid leukemia: To establish IL1RAP as an actionable biological target for NKt-AML cell elimination, we tested the internalization potential of IL1RAP antibodies upon IL1RAP binding at the surface of AML cells, which is a pre-requisite for drug release by antibody–drug conjugates (ADCs).